Company CVAbout Piramal Enterprises Ltd 
Piramal Enterprises Ltd
Large Cap
Finance/NBFC
Piramal Enterprises Limited (PEL), erstwhile Piramal Healthcare Limited, is the flagship company of the Piramal Group, led by Ajay Piramal. Established in the 1980's, the Group is one of India's powerhouse conglomerates with a track record of establishing successful businesses in varied industries. With a history of successful organic and inorganic growth ventures, the Piramal Group today has a global presence across 30 countries.
Company Coordinates
Company Details
Piramal Ananta Agastya Corp Pa, LBS Marg Kurla (W) Mumbai Maharashtra : 400070
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 45.10 Cr
Number of Shares
22.55 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-May-2024
22.55
45.10
814000
2
Issued under ESOP Scheme
18-Sep-2023
22.47
44.93
-14000000
2
Buy Back of Shares
28-Jun-2021
23.87
47.73
1535944
2
Conversion of CCD
14-Jun-2021
23.71
47.43
11589400
2
Debenture Conversion
30-Dec-2019
22.55
45.11
26385861
2
Right Issues
30-Dec-2019
22.55
45.11
26385861
2
Right Issues
08-Sep-2019
19.88
39.77
66
2
Right share kept in abeyance issued
08-Sep-2019
19.88
39.77
66
2
Right share kept in abeyance issued
30-Jun-2019
19.89
39.78
47275
2
As Per Shareholding Pattern
30-Jun-2019
19.89
39.78
47275
2
As Per Shareholding Pattern
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 29 Schemes (6.81%)
FIIs
Held by 176 FIIs (16.43%)
Promoter with highest holding
Anutham Realty Private Limited (24.91%)
Highest Public shareholder
Life Insurance Corporation Of India (4.49%)
Individual Investors Holdings
16.05%
Board of Directors
Management
Designation
Remuneration
Ajay G Piramal
Chairman & Exec. Director
0
Swati A Piramal
Vice Chairperson
0
Nandini Piramal
Executive Director
0
S Rama Dorai
Independent Director
49.5 lacs
Anand Piramal
Non Executive Director
0
Bipin Singh
Company Sec. & Compli. Officer
0
Vijay Shah
Non Executive Director
0
Suhail Nathani
Independent Director
50.0 lacs
KUNAL BAHL
Independent Director
45.0 lacs
Anjali Bansal
Independent Director
47.0 lacs
Shikha Sharma
Non Executive Director
45.0 lacs
Puneet Yadu Dalmia
Independent Director
44.5 lacs
Anita M George
Independent Director
42.5 lacs
Rajiv Mehrishi.
Independent Director
44.0 lacs
Gautam Doshi
Independent Director
24.5 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals
1,818.24
49.52%
Income from Financing Activities
1,489.75
40.58%
Service Income
292.15
7.96%
Pharmaceuticals
Pharmaceuticals
Income from Financing Activities
Income from Financing Activities
Service Income
Service Income
Stock DNARevenue and Profits:
Net Sales:
2,449 Cr
(Quarterly Results - Dec 2024)
Net Profit:
39 Cr
Finance/NBFC
INR 21,874 Cr (Large Cap)
NA (Loss Making)
20
1.06%
2.14
-0.06%
0.79
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
